Biocore to patent a test for cervical cancer.

Published: 2006-01-26 06:59:00

Updated: 2006-01-26 06:59:00

Biocore announced on Jan. 2 that a genetic diagnostic method of HPV infection was patented in Korea, which was newly designed by the use of a suspension array microsphere bead unlike the conventional DNA chip method.

The company explained that the conventional DNA chip was to put the gene samp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK